FDA Inspection 1041070 — McKesson Pharmaceuticals Corporation
The FDA completed an inspection of McKesson Pharmaceuticals Corporation on February 1, 2018 in West Sacramento, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 1, 2018
- Fiscal Year
- 2018
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- West Sacramento, CA (United States)